MeVis Medical Solutions AG

Regulatory Filings • Jun 16, 2008

News Details

Corporate | 16 June 2008 12:08

MeVis Medical Solutions widening research basis

MeVis Medical Solutions AG / Disposal

Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

MeVis Medical Solutions widening research basis:
MeVis Research becomes Fraunhofer Institute

Bremen, June 16, 2008. MeVis Medical Solutions AG [ISIN DE000A0LBFE4], a
specialist in disease-oriented software solutions for image-based medicine,
is widening its research basis.

With the planned conversion of its non-profit subsidiary MeVis Research
GmbH into a Fraunhofer Institute, the number of researcher positions will
be increased substantially. 'As a result, MeVis’ Bremen-based facility will
become the largest research center for clinical software applications for
image-based medicine in Europe', says Dr. Carl J.G. Evertsz, President and
CEO of MeVis Medical Solutions. The strategic partnership between MeVis
Medical Solutions and MeVis Research will be retained even after the latter
company’s integration into Fraunhofer Gesellschaft. 'MeVis Medical
Solutions is planning to additionally strengthen the already close ties
with MeVis Research and to extend them to include other innovative areas of
research,' Evertsz added.

In order for the planned conversion of MeVis Research into a legally
independent Fraunhofer Institut to be implemented, Mevis Medical Solutions
will initially be required to hand back its 25.1 percent share to the Free
Hanseatic City of Bremen. This is planned for the end of June 2008. The
transaction does not entail any book losses for MeVis Medical Solutions.
Full integration of MeVis Research into Fraunhofer Gesellschaft is expected
for the end of 2008. These plans were approved in a decision of the
Fraunhofer committee as and are still subject to anti-trust clearance.

MeVis Medical Solutions AG is one of the world’s leading independent
producers of software products for medical-imaging technology, particularly
digital radiology. Over the past few years, there has been an enormous
increase in the complexity and volume of medical image data derived from
imaging modalities such as computer tomography (CT) and magnet resonance
tomography (MRT). MeVis products analyze and process this data in such a
way as to provide medical practitioners with crucial information on the
diseases and organs in question for early detection, diagnosis and
intervention in the areas of oncology, neurology and surgery. The Company
develops its software solutions in close cooperation with medical experts
worldwide, and with the world’s leading original equipment manufacturers
(OEMs) in the medical technology sector and primarily markets this software
via these OEM part-nerships.

Company contact:
MeVis Medical Solutions AG
Dr. Kai Holtmann
Tel: +49 421 22495-63
E-mail: kai.holtmann@mevis.de

Press contact:
HOSCHKE & CONSORTEN Public Relations GmbH
Fabian Lorenz, Grit Pauli
Tel: +49 40 3690 50-56 / -31
E-mail: f.lorenz@hoschke.de; g.pauli@hoschke.de

16.06.2008 Financial News transmitted by DGAP

Language: English
Issuer: MeVis Medical Solutions AG
Universitätsallee 29
28359 Bremen
Deutschland
Phone: +49 421 330 74-0
Fax: +49 421 330 74-50
E-mail: office.mms@mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Stuttgart, München, Düsseldorf

End of News DGAP News-Service

---